Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Dermatology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: UCB Pharma
OpenAlex ID: W1572018981
